Organizing Committee - Scientific Committee

Organizing Committee

The members of the Organizing Committee (OC) are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Back to top

Scientific Committee

The members of Scientific Committee are hand-picked by the Organizing Committee (OC) and the conference secretariat based on their significant contributions and commitment to the field. They assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

Beau Ances, MD, Washington University in St. Louis, USA
Bruce Brew, MD, St. Vincent's Hospital, Australia
Daniel Duprez, MD, University of Minnesota, USA
Meredith Greene, MD, University of California, San Francisco, USA
Steven Grinspoon, MD, Massachusetts General Hospital, USA
Marica Holstad, PhD, Emory University, Atlanta, Georgia, USA
Amy Justice, MD, PhD, Yale School of Public Health, USA
Jordan Lake, MD, MSc, UTHealth, USA
Alan Landay, PhD, Rush University Medical Center, USA
Michael Lederman, MD, Case Western Reserve University, USA
Avindra Nath, MD, National Institutes of Health, USA
Eugènia Negredo, MD, PhD, Universitat Autònoma de Barcelona, Spain
Molly Perkins, PhD, Emory University, Atlanta, Georgia, USA
Sean Rourke, PhD, University of Toronto, Canada
Victor Valcour, MD, University of California, San Francisco, USA
Cara Wilson, MD, University of Colorado, USA

Industry Liaison Board

The Industry Liaison Board, consisting of leading medical scientists of the pharmaceutical industry, is asked to give input and suggestions that help the Organizing Committee in planning the workshop and providing support on topics of interest and innovative suggestions to optimize audience participation. The Industry Liaison Board assists the Organizing Committee by suggesting the most current and critical topics to bring the audience up-to-date on the most current research in the pharmaceutical industry in related disciplines.

Andrew Clark, MD, ViiV, UK
Richard Haubrich, MD, Gilead Sciences, USA
Christian Marsolais, PhD, Theratechnologies, Canada




Back to top